Resources VIDEOS 0:58 CV Reduction was generally consistent across baseline HbA1c 0:59 Patients could live longer with Jardiance 01:01 Relative risk reduction of CV death by more than 1/3 01:01 Early impact on risk reduction of CV death 01:03 Reduction of CV death was achieved ontop of standard of care 01:24 Actilyse Reconstitution Video 01:24 Mode of Action Video 21:08 DR DUIM: ACUTE STROKE MANAGEMENT 03:36 Dr. Todd C.Villines: Pradaxa vs other NOACs 00:32 Life happens: Car accidents 00:49 Life happens: How emergency situations affect life of patients on OAC treatment 00:42 Life happens: Appendicitis is one of the most frequent abdominal surgical emergencies 01:29 Idarucizumab (Praxbind®) patient case in gallbladder removal 03:00 Idarucizumab (Praxbind®) real patient cases 06:12 Reversibility of NOAC therapies: the neurologist's perspective 01:18 Dosage & Administration 1:01 Mode of Action Video 06:52 NOAC safety in clinical practice: Evidence from the real world 02:53 Mode of Action Video 03:16 NOACS What The Past 5 Years Taught Us 03:50 From Clinical Trials To RWE info Graphic Video 02:52 GLORIA-AF Info Graphic video 05:36 Thrive Summit Overview 31:27 Dr. Bhana – TDM: Current Treatment Therapies Load more
